Canton Strategic Holdings Inc

NASDAQ: CNTN · Healthcare · Biotechnology

PublicHQ Red Bank, NJ · MonmouthCIK 0001861657Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH 63DQ —GM —SS 34

v0.1 · 35/100 weight · pillars only

↑ balance-sheet leverage, return on assets · ↓ listing tenure, Piotroski F

Methodology →

Revenue TTM

$1.5M

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$35.9M

Employees

as of 2026-08-18

Market cap

$152.7M

as of 2026-08-18

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$35.9M-$35.9M2025

Operating income-$20.1M-$20.1M2025

Total assets$519.1M$519.1M2025

Liabilities$121.2M$121.2M2025

Equity$397.9M$397.9M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Canton Strategic Holdings Inc’s financial profile?

Canton Strategic Holdings Inc earned -$35.9M in FY2025 net income.

Peers · Healthcare

Conexeu Sciences Inc.——Tenaya Therapeutics, Inc.——Armata Pharmaceuticals, Inc.——Indaptus Therapeutics, Inc.——NervGen Pharma Corp. Common stock——Milestone Pharmaceuticals Inc.——

Neighbors

Monmouth →

Commvault Systems, Inc.$1.2B81B+UMH Properties, Inc.$35.0M60C Hovnanian Enterprises, Inc.$3.0B68B Climb Global Solutions, Inc.$652.5M76B+Cherry Hill Mortgage Investment Corporation——Change Agents Corp.——

Key facts

CEOMark Wendland

SectorHealthcare

IndustryBiotechnology

HeadquartersRed Bank, NJ

ExchangeNASDAQ: CNTN

Employees12

IPO date2024-03-28

Latest filings

8-K2026-08-14 10-Q2026-08-14 8-K2026-07-23 8-K2026-07-17 DEF 14A2026-06-25 8-K2026-06-16 10-Q2026-05-13 10-K2026-03-31

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.